[HTML][HTML] A prospective, randomized, double-blind, placebo-controlled trial of polyphenols on the outcomes of inflammatory factors and oxidative stress in patients with …

M Grabež, R Škrbić, MP Stojiljković, V Vučić… - Reviews in …, 2022 - imrpress.com
Background: Type 2 diabetes mellitus (T2DM) is commonly associated with hyperglycemia,
dyslipidemia, oxidative stress and inflammation which are well known cardiovascular risk …

[PDF][PDF] A prospective, randomized, double-blind, placebo-controlled trial of polyphenols on the outcomes of inflammatory factors and oxidative stress in patients with …

M Grabež, R Škrbić, MP Stojiljković, V Vučić… - Rev. Cardiovasc …, 2022 - article.imrpress.com
Background: Type 2 diabetes mellitus (T2DM) is commonly associated with hyperglycemia,
dyslipidemia, oxidative stress and inflammation which are well known cardiovascular risk …

A prospective, randomized, double-blind, placebo-controlled trial of polyphenols on the outcomes of inflammatory factors and oxidative stress in patients with type 2 …

M Grabez, R Škrbić, M Stojiljković, V Vucic, V Grujic… - 2022 - scidar.kg.ac.rs
Background: Type 2 diabetes mellitus (T2DM) is commonly associated with hyperglycemia,
dyslipidemia, oxidative stress and inflammation which are well known cardiovascular risk …

[PDF][PDF] A prospective, randomized, double-blind, placebo-controlled trial of polyphenols on the outcomes of inflammatory factors and oxidative stress in patients with …

M Grabež, R Škrbić, MP Stojiljković, V Vučić… - Rev. Cardiovasc …, 2022 - academia.edu
Background: Type 2 diabetes mellitus (T2DM) is commonly associated with hyperglycemia,
dyslipidemia, oxidative stress and inflammation which are well known cardiovascular risk …

[PDF][PDF] A prospective, randomized, double-blind, placebo-controlled trial of polyphenols on the outcomes of inflammatory factors and oxidative stress in patients with …

M Grabež, R Škrbić, MP Stojiljković, V Vučić… - Rev. Cardiovasc …, 2022 - scholar.archive.org
Background: Type 2 diabetes mellitus (T2DM) is commonly associated with hyperglycemia,
dyslipidemia, oxidative stress and inflammation which are well known cardiovascular risk …

A prospective, randomized, double-blind, placebo-controlled trial of polyphenols on the outcomes of inflammatory factors and oxidative stress in patients with type 2 …

M Grabež, R Škrbić, MP Stojiljković, V Vučić, VR Grujić… - 2022 - pubmed.ncbi.nlm.nih.gov
Background Type 2 diabetes mellitus (T2DM) is commonly associated with hyperglycemia,
dyslipidemia, oxidative stress and inflammation which are well known cardiovascular risk …

A prospective, randomized, double-blind, placebo-controlled trial of polyphenols on the outcomes of inflammatory factors and oxidative stress in patients with type 2 …

M Grabež, R Škrbić, MP Stojiljković… - Reviews in …, 2022 - search.ebscohost.com
Background: Type 2 diabetes mellitus (T2DM) is commonly associated with hyperglycemia,
dyslipidemia, oxidative stress and inflammation which are well known cardiovascular risk …

A prospective, randomized, double-blind, placebo-controlled trial of polyphenols on the outcomes of inflammatory factors and oxidative stress in patients with type 2 …

M Grabež, R Škrbić, MP Stojiljković, V Vučić… - Reviews in …, 2022 - europepmc.org
Background Type 2 diabetes mellitus (T2DM) is commonly associated with hyperglycemia,
dyslipidemia, oxidative stress and inflammation which are well known cardiovascular risk …

[PDF][PDF] A prospective, randomized, double-blind, placebo-controlled trial of polyphenols on the outcomes of inflammatory factors and oxidative stress in patients with …

M Grabež, R Škrbić, MP Stojiljković, V Vučić… - Rev. Cardiovasc …, 2022 - researchgate.net
Background: Type 2 diabetes mellitus (T2DM) is commonly associated with hyperglycemia,
dyslipidemia, oxidative stress and inflammation which are well known cardiovascular risk …